Interview
Katrin Ericson | LeadersLink
- RRP aims to improve the quality of life and prevent cancer for patients with Runx1 familial platelet disorder while establishing a broader pathway for cancer prevention.
- Achieving these goals requires a non-linear approach utilizing insights from diverse healthcare ecosystem experts, with specific reliance on the Faster Cures and Milken Institute networks.
- Planned strategic activities include a period of research into venture philanthropy to determine the viability, timing, and structural design of a formal program.
- Financial structures for venture philanthropy may be implemented as straightforward milestone-based arrangements with revenue sharing or as proprietary models.
- Establishing a venture philanthropy program is expected to require significant capital, typically at least one million dollars, and sufficient disease mechanism understanding to de-risk investment for for-profit entities.
- Successful engagement of for-profit partners necessitates a well-established patient community and the involvement of expert scientific key opinion leaders.
- A roadmap for venture philanthropy will be developed sequentially, requiring ongoing collection of disease-specific inputs rather than a single initial data collection phase.
- Future perspectives will be shaped by understanding the views of multiple stakeholders, including biotech executives and academics, regarding the strategic fit of venture philanthropy.
- The organization intends to launch the Cures Playbook podcast to disseminate learnings from healthcare leaders, focusing on business, scientific strategy, and leadership drivers of success.
- The execution of these plans anticipates significant challenges and failures, requiring perseverance, faith, and adaptive leadership responses to move forward.